BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the net proceeds from the offering to purchase gold bullion, support working capital, and for general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Proposed Public Offering
BioSig intends to offer shares of common stock through the underwritten public offering.
Use of Proceeds
The net proceeds will be used to purchase gold bullion, provide working capital, and for general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
- The completion of the offering is subject to market conditions with uncertainties regarding timing, size, and terms.
- Investors are advised to read the preliminary prospectus supplement and accompanying base prospectus before investing in the offering.
The proposed public offering by BioSig Technologies Inc. marks a strategic move to raise capital for various purposes and engage investors in its growth journey.